UBS AM’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.5M | Buy |
1,526,922
+6,551
| +0.4% | +$160K | 0.01% | 698 |
|
|
2025
Q4 | $34.4M | Sell |
1,520,371
-14,900
| -1% | -$324K | 0.01% | 697 |
|
|
2025
Q3 | $30.9M | Sell |
1,535,271
-796,567
| -34% | -$13.3M | 0.01% | 699 |
|
|
2025
Q2 | $33.3M | Buy |
2,331,838
+538,501
| +30% | +$6.29M | 0.01% | 833 |
|
|
2025
Q1 | $18.8M | Buy |
1,793,337
+76,408
| +4% | +$864K | ﹤0.01% | 990 |
|
|
2024
Q4 | $20.8M | Buy |
1,716,929
+206,482
| +14% | +$2.7M | ﹤0.01% | 930 |
|
|
2024
Q3 | $22.2M | Sell |
1,510,447
-44,370
| -3% | -$618K | 0.01% | 903 |
|
|
2024
Q2 | $22.4M | Buy |
1,554,817
+751,807
| +94% | +$12M | 0.01% | 826 |
|
|
2024
Q1 | $13.1M | Buy |
803,010
+5,712
| +0.7% | +$89.3K | ﹤0.01% | 914 |
|
|
2023
Q4 | $11.9M | Buy |
797,298
+35,237
| +5% | +$399K | ﹤0.01% | 929 |
|
|
2023
Q3 | $8.57M | Sell |
762,061
-1,232,415
| -62% | -$14.3M | ﹤0.01% | 1005 |
|
|
2023
Q2 | $18.7M | Hold |
1,994,476
| – | – | 0.01% | 783 |
|
|
2023
Q1 | $18.7M | Buy |
1,994,476
+8,779
| +0.4% | +$104K | 0.01% | 783 |
|
|
2022
Q4 | $24.3M | Sell |
1,985,697
-81,267
| -4% | -$1.01M | 0.01% | 707 |
|
|
2022
Q3 | $25.7M | Sell |
2,066,964
-50,691
| -2% | -$886K | 0.01% | 704 |
|
|
2022
Q2 | $41.6M | Buy |
2,117,655
+568,986
| +37% | +$13.5M | 0.02% | 585 |
|
|
2022
Q1 | $40.4M | Sell |
1,548,669
-31,622
| -2% | -$842K | 0.02% | 664 |
|
|
2021
Q4 | $44.8M | Buy |
1,580,291
+17,297
| +1% | +$538K | 0.02% | 686 |
|
|
2021
Q3 | $49.8M | Sell |
1,562,994
-7,833
| -0.5% | -$263K | 0.02% | 618 |
|
|
2021
Q2 | $54.5M | Sell |
1,570,827
-779,898
| -33% | -$25.7M | 0.02% | 623 |
|
|
2021
Q1 | $69.2M | Buy |
2,350,725
+495,943
| +27% | +$15.3M | 0.03% | 528 |
|
|
2020
Q4 | $56.9M | Sell |
1,854,782
-601,800
| -24% | -$18.4M | 0.03% | 571 |
|
|
2020
Q3 | $68.6M | Sell |
2,456,582
-335,230
| -12% | -$8.5M | 0.04% | 436 |
|
|
2020
Q2 | $59.9M | Sell |
2,791,812
-4,758,092
| -63% | -$105M | 0.04% | 441 |
|
|
2020
Q1 | $169M | Sell |
7,549,904
-1,685,616
| -18% | -$46.2M | 0.12% | 172 |
|
|
2019
Q4 | $272M | Buy |
9,235,520
+2,194,950
| +31% | +$59.6M | 0.17% | 119 |
|
|
2019
Q3 | $187M | Buy |
7,040,570
+1,957,520
| +39% | +$58.7M | 0.13% | 174 |
|
|
2019
Q2 | $172M | Buy |
5,083,050
+1,947,153
| +62% | +$63.2M | 0.12% | 187 |
|
|
2019
Q1 | $101M | Buy |
3,135,897
+2,678,700
| +586% | +$82.4M | 0.07% | 286 |
|
|
2018
Q4 | $14.4M | Buy |
457,197
+405,636
| +787% | +$13.3M | 0.01% | 774 |
|
|
2018
Q3 | $1.8M | Buy |
+51,561
| New | +$1.81M | ﹤0.01% | 1537 |
|
Other funds holding ELAN
VPM
VCM
